Lisanti Capital Growth’s AdaptHealth AHCO Stock Holding History

Lisanti Capital Growth’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-140,550	Closed	-$2.7M	–	110
2022 Q4	$2.7M	Buy	+140,550	New	+$2.97M	0.37%	97
2021 Q1	–	Sell	-144,940	Closed	-$5.44M	–	124
2020 Q4	$5.44M	Buy	+144,940	New	+$4.48M	0.75%	58

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lisanti Capital Growth's AHCO Position: Q1 2023 in Review

Lisanti Capital Growth sold out of AdaptHealth (AHCO) in Q1 2023, closing a stake of 140,550 shares — an estimated $2.7M sold.

Lisanti Capital Growth first reported a position in AHCO in Q4 2020 and held it in 2 quarters. The position peaked at $5.44M in Q4 2020. 172 funds tracked by Wall St. Rank hold AHCO as of Q1 2023.

Lisanti Capital Growth reported no remaining AdaptHealth position as of Q1 2023 after selling out during the quarter.
Lisanti Capital Growth sold 140,550 AdaptHealth shares in Q1 2023, an estimated $2.7M.
Lisanti Capital Growth first reported a position in AdaptHealth in Q4 2020 and held it in 2 quarters.
Lisanti Capital Growth's AdaptHealth position peaked at $5.44M in Q4 2020.
172 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2023.

Based on Lisanti Capital Growth's 13F filing for Q1 2023, filed 8 May 2023.